| For: | Zhao XH, Wang ZR, Chen CL, Di L, Bi ZF, Li ZH, Liu YM. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice. World J Gastroenterol 2019; 25(1): 138-150 [PMID: 30643364 DOI: 10.3748/wjg.v25.i1.138] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v25/i1/138.htm |
| Number | Citing Articles |
| 1 |
Dannel Yeo, Althea Bastian, Heidi Strauss, Payal Saxena, Peter Grimison, John E. J. Rasko. Exploring the Clinical Utility of Pancreatic Cancer Circulating Tumor Cells. International Journal of Molecular Sciences 2022; 23(3) doi: 10.3390/ijms23031671
|
| 2 |
Zinan Zhao, Ran Cui, Muladili Mutailipu, Fuguo Liu, Tianxiao Mei, Yihui Hu, Bo Chen. Revolutionizing PDAC Treatment: Exploring the Potential of CTC Detection. Nano LIFE 2026; 16(03) doi: 10.1142/S1793984425300031
|
| 3 |
Xiaoguang Wang, Lingyu Hu, Xiaodan Yang, Fei Chen, Haokai Xu, Haitao Yu, Zhengwei Song, Jianguo Fei, Zhengxiang Zhong. Clinical prognostic value of circulating tumor cells in the treatment of pancreatic cancer with gemcitabine chemotherapy. Experimental and Therapeutic Medicine 2021; 22(4) doi: 10.3892/etm.2021.10574
|
| 4 |
Kunjie Zhu, Panchun Li, Yongzhen Mo, Jie Wang, Xianjie Jiang, Junshang Ge, Weilun Huang, Yan Liu, Yanyan Tang, Zhaojian Gong, Qianjin Liao, Xiaoling Li, Guiyuan Li, Wei Xiong, Zhaoyang Zeng, Jianjun Yu. Neutrophils: Accomplices in metastasis. Cancer Letters 2020; 492 doi: 10.1016/j.canlet.2020.07.028
|
| 5 |
Zahra Eslami-S, Luis Enrique Cortés-Hernández, Catherine Alix-Panabières. Epithelial Cell Adhesion Molecule: An Anchor to Isolate Clinically Relevant Circulating Tumor Cells. Cells 2020; 9(8) doi: 10.3390/cells9081836
|
| 6 |
维忠 孙. Advances in Clinical Research on Solid Tumor Circulating Tumor Cells and Their EMT Typing. Advances in Clinical Medicine 2022; 12(04) doi: 10.12677/ACM.2022.124461
|
| 7 |
Thomas L. Sutton, Ranish K. Patel, Ashley N. Anderson, Stephen G. Bowden, Riley Whalen, Nicole R. Giske, Melissa H. Wong. Circulating Cells with Macrophage-like Characteristics in Cancer: The Importance of Circulating Neoplastic-Immune Hybrid Cells in Cancer. Cancers 2022; 14(16) doi: 10.3390/cancers14163871
|
| 8 |
Phung Thanh Huong, Sanjeev Gurshaney, Nguyen Thanh Binh, Anh Gia Pham, Huy Hoang Nguyen, Xuan Thanh Nguyen, Hai Pham-The, Phuong-Thao Tran, Khanh Truong Vu, Nhuong Xuan Duong, Claudio Pelucchi, Carlo La Vecchia, Paolo Boffetta, Hung D. Nguyen, Hung N. Luu. Emerging Role of Circulating Tumor Cells in Gastric Cancer. Cancers 2020; 12(3) doi: 10.3390/cancers12030695
|
| 9 |
Yixuan Zhang, Haochen Su, Haibo Wang, Chenghu Xu, Siqi Zhou, Jing Zhao, Shanshan Shen, Guifang Xu, Lei Wang, Xiaoping Zou, Shu Zhang, Ying Lv. Endoscopic Ultrasound-Guided Acquisition of Portal Venous Circulating Tumor Cells as a Potential Diagnostic and Prognostic Tool for Pancreatic Cancer. Cancer Management and Research 2021; doi: 10.2147/CMAR.S330473
|
| 10 |
Consuelo Amantini, Maria Beatrice Morelli, Massimo Nabissi, Francesco Piva, Oliviero Marinelli, Federica Maggi, Francesca Bianchi, Alessandro Bittoni, Rossana Berardi, Riccardo Giampieri, Giorgio Santoni. Expression Profiling of Circulating Tumor Cells in Pancreatic Ductal Adenocarcinoma Patients: Biomarkers Predicting Overall Survival. Frontiers in Oncology 2019; 9 doi: 10.3389/fonc.2019.00874
|
| 11 |
Junna He, Ronglin Bai, Xuehu Song, Yu Wang, Yichuan Zhang, Zhulin Luo. LncRNA LINC02381/miR-133b axis promotes tumorigenesis and predicts survival in pancreatic cancer. Discover Oncology 2025; 16(1) doi: 10.1007/s12672-025-03583-z
|
| 12 |
Tony C.Y. Pang, Joseph W. Po, Therese M. Becker, David Goldstein, Romano C. Pirola, Jeremy S. Wilson, Minoti V. Apte. Circulating tumour cells in pancreatic cancer: A systematic review and meta-analysis of clinicopathological implications. Pancreatology 2021; 21(1) doi: 10.1016/j.pan.2020.11.022
|
| 13 |
Kai Luo, Xiangkun Wang, Xudong Zhang, Zhongyuan Liu, Shuai Huang, Renfeng Li. The Value of Circulating Tumor Cells in the Prognosis and Treatment of Pancreatic Cancer. Frontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.933645
|
| 14 |
Danfeng Lin, Lesang Shen, Meng Luo, Kun Zhang, Jinfan Li, Qi Yang, Fangfang Zhu, Dan Zhou, Shu Zheng, Yiding Chen, Jiaojiao Zhou. Circulating tumor cells: biology and clinical significance. Signal Transduction and Targeted Therapy 2021; 6(1) doi: 10.1038/s41392-021-00817-8
|
| 15 |
Taylor C. Brown, Narendra V. Sankpal, William E. Gillanders. Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition. Biomolecules 2021; 11(7) doi: 10.3390/biom11070956
|
| 16 |
Bozena Smolkova, Agapi Kataki, Julie Earl, Ignacio Ruz-Caracuel, Marina Cihova, Maria Urbanova, Verona Buocikova, Sandra Tamargo, Vita Rovite, Helvijs Niedra, Joerg Schrader, Yvonne Kohl. Liquid biopsy and preclinical tools for advancing diagnosis and treatment of patients with pancreatic neuroendocrine neoplasms. Critical Reviews in Oncology/Hematology 2022; 180 doi: 10.1016/j.critrevonc.2022.103865
|
| 17 |
Luis Ortega Medina, M Jesús Fernández Aceñero, Cristina Díaz del Arco. Liquid biopsy for gastric cancer: Techniques, applications, and future directions. World Journal of Gastroenterology 2024; 30(12): 1680-1705 doi: 10.3748/wjg.v30.i12.1680
Abstract(916) |
Core Tip(1001) |
Full Article(HTML)(6740)
|
Full Article (PDF)-3338K(379)
|
Full Article with Cover (PDF)-3511K(340)
|
Full Article (XML)-463K(180)
|
Audio-946K(12)
|
Peer-Review Report-332K(158)
|
Answering Reviewers-92K(154)
|
Supplementary Material-1013K(172)
|
Times Cited (11)
|
Total Visits (8881)
|
Open
|
| 18 |
Jeremy G. T. Wurtzel, Sophia Lazar, Sonali Sikder, Kathy Q. Cai, Igor Astsaturov, Andrew S. Weyrich, Jesse W. Rowley, Lawrence E. Goldfinger, Muller Fabbri. Platelet microRNAs inhibit primary tumor growth via broad modulation of tumor cell mRNA expression in ectopic pancreatic cancer in mice. PLOS ONE 2021; 16(12) doi: 10.1371/journal.pone.0261633
|
| 19 |
Chuan Yang, Can Liu, Chenglai Xia, Liwu Fu. Clinical applications of circulating tumor cells in metastasis and therapy. Journal of Hematology & Oncology 2025; 18(1) doi: 10.1186/s13045-025-01733-y
|
| 20 |
Jiarong Bian, Ke Yan, Na Liu, Xingxiang Xu. Correlations between circulating tumor cell phenotyping and 18F-fluorodeoxyglucose positron emission tomography uptake in non-small cell lung cancer. Journal of Cancer Research and Clinical Oncology 2020; 146(10) doi: 10.1007/s00432-020-03244-4
|
| 21 |
Wenting Wang, Zhijian Xu, Ning Wang, Ruyong Yao, Tao Qin, Hao Lin, Lu Yue. Prognostic value of eight immune gene signatures in pancreatic cancer patients. BMC Medical Genomics 2021; 14(1) doi: 10.1186/s12920-020-00868-w
|
| 22 |
Zeru Li, Cheng Qin, Bangbo Zhao, Tianyu Li, Yutong Zhao, Xiangyu Zhang, Weibin Wang. Circulating tumor cells in pancreatic cancer: more than liquid biopsy. Therapeutic Advances in Medical Oncology 2024; 16 doi: 10.1177/17588359241284935
|
| 23 |
Zhen Tan, Josephine Mun-Yee Ko, Valen Zhuoyou Yu, Ka-On Lam, Dora Lai-Wan Kwong, Ian Yu-Hong Wong, Fion Siu-Yin Chan, Claudia Lai-Yin Wong, Kwan-Kit Chan, Tsz-Ting Law, Faith Sin-Fai Choy, Hoi-Yan Ng, Simon Ying-Kit Law, Maria Li Lung. Multigene Profiling of Circulating Tumor Cells in Esophageal Squamous Cell Carcinoma Identifies Prognostic Cancer Driver Genes Associated with Epithelial-Mesenchymal-Transition Progression and Chemoresistance. Cancers 2023; 15(22) doi: 10.3390/cancers15225329
|
| 24 |
Jerry Xiao, Reetu Mukherji, George Sidarous, Shravanthy Suguru, Marcus Noel, Benjamin A. Weinberg, Aiwu He, Seema Agarwal. Longitudinal Circulating Tumor Cell Collection, Culture, and Characterization in Pancreatic Adenocarcinomas. Cancers 2025; 17(3) doi: 10.3390/cancers17030355
|
| 25 |
Gaetan Aime Noubissi Nzeteu, Claudia Geismann, Alexander Arlt, Frederik J. H. Hoogwater, Maarten W. Nijkamp, N. Helge Meyer, Maximilian Bockhorn. Role of Epithelial-to-Mesenchymal Transition for the Generation of Circulating Tumors Cells and Cancer Cell Dissemination. Cancers 2022; 14(22) doi: 10.3390/cancers14225483
|
| 26 |
Carolina Reduzzi, Eleonora Nicolo’, Surbhi Singhal, Konstantinos Venetis, Ana Ortega-Franco, Diego de Miguel-Perez, Angelo Dipasquale, Mohamed A. Gouda, Erick F. Saldanha, Pashtoon M. Kasi, Eloisa Jantus-Lewintre, Nicola Fusco, Umberto Malapelle, David R. Gandara, Christian Rolfo, Maria Jose Serrano, Massimo Cristofanilli. Unveiling the impact of circulating tumor cells: Two decades of discovery and clinical advancements in solid tumors. Critical Reviews in Oncology/Hematology 2024; 203 doi: 10.1016/j.critrevonc.2024.104483
|
| 27 |
Thomas L. Sutton, Brett S. Walker, Melissa H. Wong. Circulating Hybrid Cells Join the Fray of Circulating Cellular Biomarkers. Cellular and Molecular Gastroenterology and Hepatology 2019; 8(4) doi: 10.1016/j.jcmgh.2019.07.002
|
| 28 |
Ahmed Bendari, Oana Vele, Brett Baskovich, Alaa Bendari, Mona Sebika, Juan Luis Gomez Marti, Kritika Krishnamurthy, Saeed Asiry. Liquid Biopsy in Pancreatic Ductal Adenocarcinoma: Clinical Utility, Trials, and Future Directions. Gastroenterology Insights 2025; 16(4) doi: 10.3390/gastroent16040039
|
| 29 |
Theodore Evan, Victoria Min-Yi Wang, Axel Behrens. The roles of intratumour heterogeneity in the biology and treatment of pancreatic ductal adenocarcinoma. Oncogene 2022; 41(42) doi: 10.1038/s41388-022-02448-x
|
| 30 |
Luana Greco, Federica Rubbino, Luigi Laghi. Epithelial to Mesenchymal Transition as Mechanism of Progression of Pancreatic Cancer: From Mice to Men. Cancers 2022; 14(23) doi: 10.3390/cancers14235797
|
| 31 |
Nerea Laura Keller, Gina Votta-Velis, José Alejandro Aguirre, Alain Borgeat. Pancreatic Circulating Tumor Cells: An Update. Onco 2026; 6(1) doi: 10.3390/onco6010013
|
| 32 |
Anabela Couto-Cunha, Carmen Jerónimo, Rui Henrique. Circulating Tumor Cells as Biomarkers for Renal Cell Carcinoma: Ready for Prime Time?. Cancers 2022; 15(1) doi: 10.3390/cancers15010287
|
| 33 |
Julie Dardare, Andréa Witz, Jean-Louis Merlin, Agathe Bochnakian, Paul Toussaint, Pauline Gilson, Alexandre Harlé. Epithelial to Mesenchymal Transition in Patients with Pancreatic Ductal Adenocarcinoma: State-of-the-Art and Therapeutic Opportunities. Pharmaceuticals 2021; 14(8) doi: 10.3390/ph14080740
|
| 34 |
Merve Yılmaz, Fuat Kaplan, Ilgen Mender, Sergei M. Gryaznov, Z. Gunnur Dikmen. Cancer Stem Cells and Anti-tumor Immunity. Current Stem Cell Research & Therapy 2023; 18(4) doi: 10.2174/1574888X18666221017142032
|
| 35 |
Charalampos Theocharopoulos, Nikolaos Machairas, Ioannis Ziogas, Benedetto Mungo, Marco Del Chiaro, Georgios Glantzounis, Richard Schulick, Georgios Sotiropoulos. Personalizing Treatment for Pancreatic Ductal Adenocarcinoma: The Emerging Role of Minimal Residual Disease in Perioperative Decision-Making. Cancers 2025; 18(1) doi: 10.3390/cancers18010094
|
| 36 |
Lifu Huang, Xianjun Zhang, Feiping Li, Xiaohong Wang, Tao Huang. MicroRNA-143-3p/TBX3 Axis Represses Malignant Cell Behaviors in Bladder Cancer. Computational and Mathematical Methods in Medicine 2022; 2022 doi: 10.1155/2022/2880087
|
| 37 |
Sharmin Aktar, Faysal Bin Hamid, Sujani Gamage, Tracie Cheng, Nahal Pakneshan, Cu Lu, Farhadul Islam, Vinod Gopalan, Alfred Lam. Gene Expression Analysis of Immune Regulatory Genes in Circulating Tumour Cells and Peripheral Blood Mononuclear Cells in Patients with Colorectal Carcinoma. International Journal of Molecular Sciences 2023; 24(5) doi: 10.3390/ijms24055051
|
| 38 |
Simran Asawa, Manuel Nüesch, Ana Gvozdenovic, Nicola Aceto. Circulating tumour cells in gastrointestinal cancers: food for thought?. British Journal of Cancer 2023; 128(11) doi: 10.1038/s41416-023-02228-8
|
| 39 |
Nele Vandenbussche, Renske Imschoot, Béatrice Lintermans, Lode Denolf, Joachim Taminau, Charlotte Fieuws, Geert Berx, Kris Gevaert, Kathleen B. M. Claes. EMT‐associated bias in the Parsortix® system observed with pancreatic cancer cell lines. Molecular Oncology 2025; 19(11) doi: 10.1002/1878-0261.70066
|
| 40 |
Zhanfeng Zhang, Chuanzhen Xie, Rong Zhao, Shuai Wang, Zaichun Xie, Zhiyu Pang, Qian Xu, Peng Zhang, Yuanrui Liu. Detecting epithelial-mesenchymal transition signaling molecules in cervical epithelial cells aids in the early diagnosis of cervical lesions. BMC Cancer 2024; 24(1) doi: 10.1186/s12885-024-13355-7
|
| 41 |
Adriana Carneiro, Paulina Piairo, Alexandra Teixeira, Dylan Ferreira, Sofia Cotton, Carolina Rodrigues, Alexandre Chícharo, Sara Abalde-Cela, Lúcio Lara Santos, Luís Lima, Lorena Diéguez. Discriminating Epithelial to Mesenchymal Transition Phenotypes in Circulating Tumor Cells Isolated from Advanced Gastrointestinal Cancer Patients. Cells 2022; 11(3) doi: 10.3390/cells11030376
|
| 42 |
Qingming Xie, Shilei Liu, Sai Zhang, Liqiu Liao, Zhi Xiao, Shouman Wang, Pengfei Zhang. Research progress on the multi-omics and survival status of circulating tumor cells. Clinical and Experimental Medicine 2024; 24(1) doi: 10.1007/s10238-024-01309-z
|
| 43 |
Kathryn L. Fowler, Ashley N. Anderson, Taelor J. Ekstrom, Nicole R. Giske, Abigail Moore, Ranish K. Patel, Amanda Zucker, Melissa H. Wong. Cell Fusion. Advances in Experimental Medicine and Biology 2026; 1509 doi: 10.1007/978-3-032-22637-2_14
|
| 44 |
Laura González-Silva, Laura Quevedo, Ignacio Varela. Tumor Functional Heterogeneity Unraveled by scRNA-seq Technologies. Trends in Cancer 2020; 6(1) doi: 10.1016/j.trecan.2019.11.010
|
| 45 |
Kirby P. Gardner, Susan Tsai, Mohammed Aldakkak, Stephen Gironda, Daniel L. Adams, Dominique Heymann. CXCR4 expression in tumor associated cells in blood is prognostic for progression and survival in pancreatic cancer. PLOS ONE 2022; 17(3) doi: 10.1371/journal.pone.0264763
|
| 46 |
Chuan-Hsin Chang, Chung-Che Tsai, Fu-Ming Tsai, Tin-Yi Chu, Po-Chih Hsu, Chan-Yen Kuo. EpCAM Signaling in Oral Cancer Stem Cells: Implications for Metastasis, Tumorigenicity, and Therapeutic Strategies. Current Issues in Molecular Biology 2025; 47(2) doi: 10.3390/cimb47020123
|
| 47 |
Seung Bae Yoon, Sung Woo Ko. Clinical Utility of Portal Venous Circulating Tumor Cells in Pancreatic Cancer. Journal of Digestive Cancer Research 2023; 11(1) doi: 10.52927/jdcr.2023.11.1.21
|
| 48 |
Tanzila Khan, Kieran F. Scott, Therese M. Becker, John Lock, Mohammed Nimir, Yafeng Ma, Paul de Souza. The Prospect of Identifying Resistance Mechanisms for Castrate-Resistant Prostate Cancer Using Circulating Tumor Cells: Is Epithelial-to-Mesenchymal Transition a Key Player?. Prostate Cancer 2020; 2020 doi: 10.1155/2020/7938280
|
| 49 |
Xiaoling Wang, Lijuan Wang, Haihong Lin, Yifan Zhu, Defa Huang, Mi Lai, Xuxiang Xi, Junyun Huang, Wenjuan Zhang, Tianyu Zhong. Research progress of CTC, ctDNA, and EVs in cancer liquid biopsy. Frontiers in Oncology 2024; 14 doi: 10.3389/fonc.2024.1303335
|
| 50 |
Yong-Gang He, Xiao-Bing Huang, Yu-Ming Li, Jing Li, Xue-Hui Peng, Wen Huang, Yi-Chen Tang, Lu Zheng. Efficacy and safety of laparoscopic radical resection following neoadjuvant therapy for pancreatic ductal adenocarcinoma: A retrospective study. World Journal of Gastrointestinal Oncology 2022; 14(9): 1785-1797 doi: 10.4251/wjgo.v14.i9.1785
|
| 51 |
Yang Wang, Xiaojin Yu, Daniel Hartmann, Jiahua Zhou. Circulating tumor cells in peripheral blood of pancreatic cancer patients and their prognostic role: a systematic review and meta-analysis. HPB 2020; 22(5) doi: 10.1016/j.hpb.2019.11.003
|
| 52 |
Jiani Yang, Jun Ma, Yue Jin, Shanshan Cheng, Shan Huang, Nan Zhang, Yu Wang. Development and validation for prognostic nomogram of epithelial ovarian cancer recurrence based on circulating tumor cells and epithelial–mesenchymal transition. Scientific Reports 2021; 11(1) doi: 10.1038/s41598-021-86122-4
|
| 53 |
Sung Woo Ko, Seung Bae Yoon. Clinical implications and perspectives of portal venous circulating tumor cells in pancreatic cancer. World Journal of Gastrointestinal Oncology 2023; 15(4): 632-643 doi: 10.4251/wjgo.v15.i4.632
|
| 54 |
Nobuhiro Haga, Akifumi Onagi, Tomoyuki Koguchi, Seiji Hoshi, Soichiro Ogawa, Hidenori Akaihata, Junya Hata, Hiroyuki Hiraki, Ruriko Honda, Ryo Tanji, Kanako Matsuoka, Masao Kataoka, Yuichi Sato, Kei Ishibashi, Yoshiyuki Kojima. Perioperative Detection of Circulating Tumor Cells in Radical or Partial Nephrectomy for Renal Cell Carcinoma. Annals of Surgical Oncology 2020; 27(4) doi: 10.1245/s10434-019-08127-8
|
| 55 |
Ryan Munnings, Peter Gibbs, Belinda Lee. Evolution of Liquid Biopsies for Detecting Pancreatic Cancer. Cancers 2024; 16(19) doi: 10.3390/cancers16193335
|
| 56 |
Risa Burr, Christine Gilles, Erik W. Thompson, Shyamala Maheswaran. Circulating Tumor Cells in Breast Cancer Metastatic Disease. Advances in Experimental Medicine and Biology 2020; 1220 doi: 10.1007/978-3-030-35805-1_2
|
| 57 |
Hee Seung Lee, Eun Hye Jung, Hyejung Shin, Chan Su Park, Soo Been Park, Dawoon E. Jung, Galam Leem, So Jung Kim, Jung Hyun Jo, Moon Jae Chung, Jeong Youp Park, Seungmin Bang, Seung Woo Park, Si Young Song. Phenotypic characteristics of circulating tumor cells and predictive impact for efficacy of chemotherapy in patients with pancreatic cancer: a prospective study. Frontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1206565
|
| 58 |
Claudia Dompé, Aleksandra Chojnowska, Rodryg Ramlau, Michal Nowicki, Catherine Alix-Panabières, Joanna Budna-Tukan. Unveiling the dynamics of circulating tumor cells in colorectal cancer: from biology to clinical applications. Frontiers in Cell and Developmental Biology 2024; 12 doi: 10.3389/fcell.2024.1498032
|
| 59 |
Anthony Genna, Aline M. Vanwynsberghe, Amélie V. Villard, Charles Pottier, Julien Ancel, Myriam Polette, Christine Gilles. EMT-Associated Heterogeneity in Circulating Tumor Cells: Sticky Friends on the Road to Metastasis. Cancers 2020; 12(6) doi: 10.3390/cancers12061632
|
| 60 |
Sha-Sha Jiang, Chun-Guo Mao, Yong-Geng Feng, Bin Jiang, Shao-Lin Tao, Qun-You Tan, Bo Deng. Circulating tumor cells with epithelial-mesenchymal transition markers as potential biomarkers for the diagnosis of lung cancer. World Journal of Clinical Cases 2021; 9(12): 2721-2730 doi: 10.12998/wjcc.v9.i12.2721
|
| 61 |
Chenglin Li, Rui Li, Xueyuan Wu, Yifan Zuo, Guixiang Xiong, Meng Huang, Yuqing Sun, Rong Liao, Yang Xiao, Lili Hu, Chao Gao, Yanyan Yu. Capture of Heterogeneous Circulating Tumor Cells in Colorectal Cancer Patients on an Immunomagnetic and Anti-Nonspecific Adsorption Platform. Analytical Chemistry 2022; 94(44) doi: 10.1021/acs.analchem.2c02416
|
| 62 |
Su Bin Lim, Wen Di Lee, Jyothsna Vasudevan, Wan-Teck Lim, Chwee Teck Lim. Liquid biopsy: one cell at a time. npj Precision Oncology 2019; 3(1) doi: 10.1038/s41698-019-0095-0
|
| 63 |
Geng Tian, Fabrice Kayitare, Xiaoyong Chen, Chong Yan, Zihao Li, Zhenlong Wang, Tie Chong, Delai Fu. A CTCs-based recurrence model for non-metastatic renal cell carcinoma: integrating machine learning and SHAP interpretation. Biomarkers in Medicine 2025; 19(21) doi: 10.1080/17520363.2025.2590789
|